| Patents for C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931) |
|---|
| 05/22/2002 | EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 05/22/2002 | EP1206456A1 Thermochromic rylene dyes |
| 05/21/2002 | US6391887 3,4-Dihydroquinoline derivatives as nitrogen monoxide synthase (NOS) inhibitors |
| 05/16/2002 | WO2002026727A3 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 05/16/2002 | WO2001087308B1 Treatment of fibromyalgia and chronic fatigue syndrome |
| 05/16/2002 | US20020058813 Spiro-indolines as Y5 receptor antagonists |
| 05/16/2002 | US20020058676 For use in therapy of arrhythmias, spasms, cardiac and cerebral ischaemia, pain and neurodegenerative diseases of various origins |
| 05/14/2002 | US6387921 Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines and their use as pharmaceutical compositions |
| 05/14/2002 | US6387905 Compounds useful for inhibition of farnesyl protein transferase |
| 05/14/2002 | US6387893 Adrenergic blocking agent; benign prosatatic hyperplasia |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/10/2002 | WO2002036573A2 8- substituted-2, 6-methano-3-benzazocines and 3-substituted morphinanes as opioid receptor binding agents |
| 05/10/2002 | WO2002036572A1 Remedies for extraocular inflammatory diseases |
| 05/10/2002 | WO2002036568A1 N-type calcium channel antagonists for the treatment of pain |
| 05/10/2002 | WO2002036545A1 Improved process for production of gabapentin intermediate |
| 05/10/2002 | CA2427237A1 Improved process for production of gabapentin intermediate |
| 05/09/2002 | US20020055635 Cycloalkano-indole and -azaindole derivatives |
| 05/09/2002 | US20020055631 N-acylsulfonamide apoptosis promoters |
| 05/08/2002 | EP1203766A2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 05/07/2002 | US6384075 Treating diseases in which mast cell dysfunction is involved |
| 05/02/2002 | WO2002034753A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | WO2001042207A3 Novel methods for the treatment and prevention of ileus |
| 05/02/2002 | EP1201656A1 Processes for the preparation of ipidacrine or ipidacrine hydrochloride hydrate |
| 05/02/2002 | EP1200446A1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS |
| 05/02/2002 | EP1200406A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/01/2002 | CN1347416A Substd. 3-cyano-[1.7], [1.5], and [1.8]-naphthyridine inhibitors of tyrosine kinases |
| 04/30/2002 | US6380211 For treating diabetes |
| 04/30/2002 | US6380193 Fused tricyclic compounds, methods and compositions for inhibiting PARP activity |
| 04/30/2002 | US6379591 Naphthopyrans annelated in C5-C6 with a lactam-type C6 ring and compositions and (co)polymer matrices containing them |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | US20020049222 Cyclopentyl modulators of chemokine receptor activity |
| 04/25/2002 | US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/24/2002 | EP1199078A1 Analgesics |
| 04/24/2002 | EP1198457A1 Quaternized azafluorenones and their use in agents for dying fibers containing keratin |
| 04/18/2002 | WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors |
| 04/18/2002 | WO2002030906A1 Anti-tumour compounds |
| 04/18/2002 | WO2002030904A1 Pyridinone derivatives for treatment of atherosclerosis |
| 04/18/2002 | WO2001015656A9 Tricyclic compounds and their uses as antiarrhythmic antifibrillatory and defibrillatory agents |
| 04/18/2002 | US20020045617 Act preferentially on M4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; Alzheimer's disease; Cognition activators. |
| 04/18/2002 | US20020045065 Novel organometallic luminescent materials and organic electroluminescent device containing same |
| 04/18/2002 | US20020045064 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines |
| 04/18/2002 | US20020045063 Metal sulfonates of metal complexes of hydroxy- and mercapto-quinolines, benzoxazoles, benzothiazoles, benzotriazoles, benzoselenazoles, benzotellurazoles and phenanthridines |
| 04/16/2002 | US6372910 Process for the manufacture of 1,8-naphthalimide |
| 04/16/2002 | US6372909 Reacting 3-phenylethyl-2-pyridinecarboxamide with dehydrating agent to cyclize and form tricyclic imine, hydrolyzing to form tricyclic ketone |
| 04/16/2002 | US6372756 Narcotics or analgesics |
| 04/16/2002 | US6372754 Drugs for treatment or prevention of depression, anxiety, pain, inflammation, migraine, emesis or postherpic neuralgia. |
| 04/16/2002 | CA2162710C Dyes designed for high sensitivity detection of double-stranded dna |
| 04/11/2002 | WO2002028837A1 Metabotropic glutamate receptor antagonists |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | US20020042515 Tetrahydroquinolines |
| 04/11/2002 | US20020042406 Ring opening metathesis of alkenes |
| 04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
| 04/10/2002 | EP1194429A1 Potassium channel openers |
| 04/10/2002 | EP0912567B1 Carboline derivatives |
| 04/10/2002 | CN1082509C Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents |
| 04/09/2002 | US6369227 Thrombin or factor Xa inhibitors |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026714A1 Spiro compounds |
| 04/04/2002 | CA2423919A1 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
| 04/03/2002 | EP1192157A1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/03/2002 | CN1343208A Pyridopyranoazepine derivatives, preparation and therapeutic use |
| 04/02/2002 | US6365597 4-aza steroids |
| 04/02/2002 | US6365588 Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 04/02/2002 | CA2051012C Carbocyclic adenosine analogs useful as immunosupressants |
| 03/28/2002 | WO2002025648A1 Optical data carrier containing a phthalocyanine colouring agent as a light absorbing compound in the information layer |
| 03/28/2002 | WO2002025205A1 Optical data storage device containing a co-phthalocyanin complex in the optically writable information layer |
| 03/28/2002 | WO2002024650A2 Pyridinone and pyridinethione derivatives having hiv inhibiting properties |
| 03/28/2002 | WO2002024636A2 N-acylsulfonamide apoptosis promoters |
| 03/28/2002 | US20020037904 Substituted 4,9-dihydrocyclopent a [imn] phenanthridine-5-ones, derivatives thereof and their uses |
| 03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1064284B1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 03/27/2002 | EP0705273B1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof |
| 03/27/2002 | CN1342161A Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362181 Bactericides; enzyme inhibitors; antitumor agents |
| 03/26/2002 | CA2222358C Dye precursor from plants of the genus medicago, its preparation and its application in obtaining dyes |
| 03/21/2002 | US20020035261 Synthesis of intermediates useful in preparing tricyclic compounds |
| 03/21/2002 | US20020034761 Methods of labelling polynucleotides with dibenzorhodamine dyes |
| 03/20/2002 | EP1188749A1 Process for the preparation of intermediate compounds of drugs |
| 03/20/2002 | EP1187810A2 Heterocyclic analgesic compounds and their use |
| 03/20/2002 | EP1187592A2 Alpha v integrin receptor antagonists |
| 03/20/2002 | EP0915851B1 Dibenzodihydropyridinecarboxylic esters and their use in chemiluminescent assay methods |
| 03/20/2002 | EP0837860B1 TRICYCLIC 5,6-DIHYDRO-9H-PYRAZOLO(3,4-c]-1,2,4-TRIAZOLO(4,3-ALPHA]PYRIDINES |
| 03/19/2002 | US6359135 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/19/2002 | US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof |
| 03/19/2002 | CA2173963C Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/13/2002 | EP1185536A2 Hemisynthetic method and intermediates thereof |
| 03/13/2002 | EP1185533A1 Naphthopyrans annelated in c5-c6 with a lactam-type c6 ring and compositions and (co)polymer containing them |
| 03/13/2002 | EP1185515A1 Method of inhibiting neurotrophin-receptor binding |
| 03/13/2002 | EP1185493A1 Quinones for treatment of diseases |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355668 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |